logo
GaldermaAnnouncesFirstPatientEnrollmentinStudytoAssessNemolizumabinAdultsWithChronicPruritusofUnknownOrigin
===2025/12/11 14:52:05===
anov@galderma.com
+41 21 642 78 12

Richard Harbinson
Corporate Communications Director
richard.harbinson@galderma.com
+41 76 210 60 62

Jessica Cohen
Investor Relations and Strategy Director
jessica.cohen@galderma.com
+41 21 642 76 43

Céline Buguet
Franchises and R&D Communications Director
celine.buguet@galderma.com
+41 76 249 90 87




=*=*=*=*=*=
当前为第10/10页
上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页